Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 567 of 6351
-
Brain gene therapy targets Parkinson's at its source
Disease control Recruiting nowParkinson's disease (PD) poses a severe threat to human health, and its incidence is rising year by year. Current therapeutic options are limited by significant shortcomings. Pathological aggregation of α-synuclein and the consequent death of dopaminergic neurons are the primary …
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:11 UTC
-
New hope for Crohn's scarring: risankizumab vs ustekinumab in major trial
Disease control Not yet recruitingThis study, titled "IL-23 Inhibitor Ustekinumab for the Treatment of Fibrotic Crohn's Disease: A Prospective, Open-Label, Randomized Controlled Study," is conducted by researchers from the First Affiliated Hospital of Wenzhou Medical University. The primary aim of this research i…
Phase 3 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 18:29 UTC
-
Heart-Safe breast cancer treatment shows promise in new trial
Disease control Recruiting nowThis is a single-arm Phase II study to assess the efficacy of a 12-18 week neoadjuvant carboplatin, paclitaxel, and pembrolizumab (CPP) regimen in a response-adaptive manner for triple-negative breast cancer (TNBC) patients who are ineligible for anthracycline-based therapy due t…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill could help control PKU – phase 3 trial now recruiting
Disease control Recruiting nowThe goal of this Phase 3, randomized study is to assess the safety, efficacy, tolerability, and pharmacokinetics (PK) of oral JNT-517 in adults (18 years of age or older) with PKU. Participants will receive either JNT-517 or placebo and will be blinded to their treatment assignme…
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Heart surgery showdown: could a simple gas beat standard anesthesia?
Disease control Recruiting nowTo investigate whether the inhaled anesthetic desflurane, compared with propofol, exerts cardioprotective effects and reduces the incidence of severe postoperative major cardiac events in patients undergoing coronary artery bypass graft (CABG) surgery.
Phase 3 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
A patch, not a surgery: new device aims to monitor heart failure without implants
Diagnosis By invitation onlyThe purpose of the study is to examine the Vivio System's ability to track heart failure status in subjects, and compare the Vivio System's measurements to CardioMEMS measurements. Heart failure, which is a form of heart disease, is a condition where the heart does not pump enoug…
Sponsor: Ventric Health, LLC • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Could simple exercises slow cognitive decline? a new trial investigates.
Symptom relief CompletedWith the aging of the population, the number of older adults with mild cognitive impairment (MCI) has increased year by year, which has caused serious social and family burdens. At present, the existing drug treatment effect is limited. Studies show the application value of non-d…
Sponsor: Jinzhou Medical University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Second chance: can a different immunotherapy drug be safely retried after lung inflammation?
Disease control Recruiting nowThis multicenter observational study will evaluate the safety and effectiveness of immune checkpoint inhibitor rechallenge in adults with lung cancer who developed checkpoint inhibitor pneumonitis. The study will use both retrospective medical records and prospective follow-up d…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could 40 hours on your belly save more lives from lung failure?
Disease control Recruiting nowAcute respiratory distress syndrome (ARDS) is an acutely induced respiratory failure characterised by the appearance of bilateral alveolar opacities on imaging and hypoxemia(1). Among strategies that have proved beneficial in terms of patient outcome, prone position (PP) is one a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can a new pill drain stubborn kidney swelling?
Disease control CompletedTo evaluate the safety,efficacy, and pharmacokinetic characteristics of JMKX003142 administered randomly, double-blind, placebo-controlled study in Chinese renal edema patients with inadequate response to conventional diuretic therapy.
Phase 2 • Sponsor: Jemincare • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can cutting protein save critically ill newborns?
Disease control CompletedThis study aims to determine the differences in outcomes in groups with protein restriction in parenteral nutrition of critically ill infants, compared with protein regimens according to local guidelines.
Sponsor: Indonesia University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New blood test could spot breast cancer early, saving lives
Diagnosis Recruiting nowCancer continues to be one of the most significant public health issues worldwide. Thanks to early detection, the mortality rate of certain types of cancer has decreased significantly. However, the lack of accessible, low-cost, non-invasive, non-toxic, and easy-to-implement diagn…
Sponsor: Oncoliq US Inc • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New immune combo targets hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study aims to preliminarily explore the efficacy and safety of Iparomlimab and Tuvonralimab in combination with Nimotuzumab for the treatment of recurrent/metastatic nasopharyngeal carcinoma (NPC). It is expected to investigate a novel therapeutic regimen with improved effic…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo therapy targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis is a Phase I/II, Open Label Study of WSD0922-FU in Combination with Osimertinib for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose disease has progressed with third-generation EGFR-TKI with C797S mutation or is newly diagnosed with CNS metastas…
Phase 1/2 • Sponsor: Wayshine Biopharm, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Lifestyle makeover may boost breast cancer treatment success
Disease control Recruiting nowThe purpose of this study is to examine whether a nutrition and exercise program can improve pathologic complete response (pCR) in women with triple-negative breast cancer (TNBC) receiving chemo-immunotherapy before surgery. Pathologic complete (pCR) response means that no cancer…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could Lab-Grown cells free diabetics from insulin shots?
Disease control By invitation onlyThis study is an open-label, single-arm, non-randomized trial designed to evaluate the safety and preliminary efficacy of CRG-002 administered via portal vein infusion or transplantation beneath the anterior rectus sheath in patients with type 1 diabetes mellitus (T1DM) or pancre…
Early phase 1 • Sponsor: Celregen Therapeutics • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Implantable stimulator aims to stop blood pressure swings in spinal cord injury
Disease control Recruiting nowEmpower BP is a pivotal, interventional, multicenter, prospective, randomized, controlled double-blinded study to evaluate the safety and effectiveness of the ARC-IM System in managing symptomatic blood pressure instability in individuals with chronic SCI (\>1 year after SCI). T…
Sponsor: ONWARD Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New sedative could help preterm babies breathe on their own faster
Disease control Recruiting nowVery preterm neonates (born before 32 weeks' gestation) often require invasive mechanical ventilation (IMV) to manage respiratory insufficiency. In France, around 8,250 infants are born annually at \<32 weeks, with an estimated 5,000 needing IMV. Although non-invasive support suc…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill could stop and treat dangerous swelling attacks
Disease control Recruiting nowThis is a Phase 3, multicenter, 3-part study, with 2 randomized, double-blind, placebo-controlled parts and an open-label extension part, to evaluate the efficacy and safety of orally administered deucrictibant XR tablet for prophylaxis, and deucrictibant IR capsule for on-demand…
Phase 3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug combo aims to shed pounds and control diabetes
Disease control Recruiting nowThe purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC